VVP-100X

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVVP-100X
Drug Alias NameVVP-100X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizers
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVerva Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVerva Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A